Novozymes Patents – Insights & Stats

Novozymes has a total of 15360 patents globally, out of which 6556 have been granted. Of these 15360 patents, more than 40% patents are active. The United States of America is where Novozymes has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, Europe seems to be the main focused R&D center, and also Denmark is the origin country of Novozymes.

Novozymes was founded in the year 2000. The Company researches, develops, produces, and sells enzymes for industrial use. Novozymes works within three main segments: the technical enzyme market, the food enzyme market, and the animal feed enzyme market.

Do read about some of the most popular patents of Novozymes which have been covered by us in this article and also you can find Novozymes patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Novozymes patent portfolio.

How many patents does the CEO of Novozymes have?

The CEO Ester Baiget has 3 patents.

How many patents does Novozymes have?

Novozymes has a total of 15360 patents globally. These patents belong to 3404 unique patent families. Out of 15360 patents, 6206 patents are active.

How Many Patents did Novozymes File Every Year?

Novozymes Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantNovozymes Applications FiledNovozymes Patents Granted
20231073
2022131281
2021293413
2020481434
2019594473
2018707498
2017609571
2016784524
2015941445
2014932418
2013953355
20121431374
2011888320

How many Novozymes patents are Alive/Dead?

Worldwide Patents

Novozymes Patents Portfolio

How Many Patents did Novozymes File in Different Countries?

Novozymes Worldwide Patents

Countries in which Novozymes Filed Patents

CountryPatents
United States Of America2996
Europe2297
China1581
Germany989
India851
Brazil684
Canada638
Denmark506
Mexico481
Australia451
Spain345
Austria327
Argentina173
Japan162
Russia145
South Africa129
Indonesia108
Korea (South)90
Poland80
Malaysia75
New Zealand64
Viet Nam41
Italy35
Taiwan35
Hong Kong (S.A.R.)29
Finland27
Chile25
Philippines23
Portugal21
Singapore21
Israel20
Norway19
Uruguay17
Eurasia15
Paraguay15
Turkey14
Peru14
Hungary13
United Kingdom12
Colombia8
Kazakhstan7
Ireland6
Africa5
Bolivia4
Pakistan4
Egypt3
Sweden3
Ukraine3
Ecuador3
Saudi Arabia3
Kenya3
Slovenia3
Bangladesh3
Panama3
Tunisia2
Brunei2
Slovakia2
Iceland1
Czech Republic1
Macao1
France1
Cyprus1
Gulf Cooperation Council1
Jordan1

Where are Research Centers of Novozymes Patents Located?

Research Centers of Novozymes Patents

10 Best Novozymes Patents

WO2011098531A1 is the most popular patent in the Novozymes portfolio. It has received 821 citations so far from companies like Danisco Us Inc, Procter & Gamble, and Basf.

Below is the list of 10 most cited patents of Novozymes:

Publication NumberCitation Count
WO2011098531A1821
WO2009109500A1786
WO2011036263A1671
WO2013001078A1665
WO2007006305A1662
WO2005040372A1642
WO2005047499A1636
WO2011036264A1590
WO2006078256A2574
US6939702B1510

How many inventions of other companies were rejected due to Novozymes patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Novozymes invention. They couldn’t because Novozymes had protected those before them.

Examiners at the USPTO referred 473 Novozymes patents in 1932 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Novozymes patent portfolio are Danisco, Procter & Gamble and the United States Department Of Energy.

List of the Companies whose Patents were rejected citing Novozymes –

CompanyNumber of Patent Applications that faced Rejection Citing Novozymes PatentsNumber of Rejections (102 & 103)
Danisco86180
Procter & Gamble51128
United States Department Of Energy47121
Henkel3890
Dsm Ip Assets Bv3574
Xyleco Inc1839
Ecolab Usa Inc1226
Basf829
Codexis812
Chevron Usa Inc717

Count of 102 and 103 Type Rejections based on Novozymes Patents

Top Novozymes Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US7354743B218
US20100304437A116
US7271244B215
US8580536B212
US7413882B211
US20050181446A111
US20050100559A110
US8097772B29
US7888093B28
US20080193999A18
US9228284B28
US20080031998A17
US20140134709A17
US7056544B27
US7498158B27

What Percentage of Novozymes US Patent Applications were Granted?

Novozymes (Excluding its subsidiaries) has filed 2375 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1394 have been granted leading to a grant rate of 64.69%.

Below are the key stats of Novozymes patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Novozymes?

Law FirmTotal ApplicationsSuccess Rate
Novozymes North America Inc202063.22%
Novozymes Inc14277.94%
Morris Fidelman1894.44%
Nixon & Vanderhye Pc12100.00%
Fidelman Wolffe & Waldron1181.82%
Hamilton Brook Smith & Reynolds1154.55%
Fidelman & Wolffe988.89%
Knobbe Martens Olson & Bear966.67%
Sughrue Mion Zinn Macpeak & Seas9100.00%
Joseph B Harris70%

What are Novozymes key innovation segments?

What Technologies are Covered by Novozymes?

The chart below distributes patents filed by Novozymes in different countries on the basis of the technology protected in patents. It also represents the markets where Novozymes thinks it’s important to protect particular technology inventions.

R&D Focus: How has Novozymes search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Novozymes?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.